LALPATHLAB
Dr. Lal Path Labs Ltd.
Pan-India diagnostics and pathology — routine and specialised testing, plus radiology
Healthcare›Healthcare›Healthcare Services›Healthcare Service Provider
lalpathlabs.com(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Stock price
₹1859.90
Market cap
31,059 Cr
Stock P/E
57.3
P/B
12.39
Dividend yield
0.7%
ROE (FY26)
19.9%
ROCE (FY26)
27.2%
Operating margin (FY26)
22.5%
OCF / EBITDA (FY26)
81.2%
OCF / EBITDA (3Y)
83.4%
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Dr. Lal PathLabs provides pathology and diagnostic testing in India through labs and collection points, with about three-quarters of its revenue from B2C customers.
Company snapshot
1stBy market cap
Ranked among 10 companies in Healthcare Service Provider.
What we see
Positives
- ✓Net margin of 18.5% — the business keeps a healthy share of every rupee it earns.
3 more signals from the filings.Sign in free to see them all
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 601 Cr | 539 Cr | 545 Cr | 602 Cr | 660 Cr | 597 Cr | 603 Cr | 670 Cr | 731 Cr | 660 Cr | 703 Cr | 798 Cr |
| Operating expenses (approx.) | 423 Cr | 398 Cr | 401 Cr | 432 Cr | 458 Cr | 443 Cr | 434 Cr | 477 Cr | 507 Cr | 480 Cr | 516 Cr | 550 Cr |
| EBITDA | 178 Cr | 141 Cr | 145 Cr | 170 Cr | 203 Cr | 154 Cr | 169 Cr | 192 Cr | 224 Cr | 179 Cr | 187 Cr | 248 Cr |
| OPM % | 29.6% | 26.1% | 26.5% | 28.2% | 30.7% | 25.8% | 28.0% | 28.7% | 30.7% | 27.2% | 26.6% | 31.0% |
| Other income | 18 Cr | 18 Cr | 18 Cr | 21 Cr | 22 Cr | 25 Cr | 26 Cr | 28 Cr | 25 Cr | 24 Cr | 24 Cr | 32 Cr |
| Interest | 8 Cr | 7 Cr | 7 Cr | 6 Cr | 6 Cr | 5 Cr | 5 Cr | 5 Cr | 5 Cr | 7 Cr | 6 Cr | 6 Cr |
| Depreciation | 36 Cr | 36 Cr | 37 Cr | 35 Cr | 35 Cr | 36 Cr | 36 Cr | 35 Cr | 41 Cr | 42 Cr | 45 Cr | 44 Cr |
| Profit before tax | 152 Cr | 116 Cr | 120 Cr | 150 Cr | 183 Cr | 138 Cr | 153 Cr | 181 Cr | 204 Cr | 124 Cr | 160 Cr | 229 Cr |
| Tax % | 27.3% | 29.1% | 28.4% | 28.1% | 28.6% | 29.1% | -1.4% | 26.0% | 25.2% | 26.5% | 17.4% | 25.4% |
| Net profit | 111 Cr | 82 Cr | 86 Cr | 108 Cr | 131 Cr | 98 Cr | 156 Cr | 134 Cr | 152 Cr | 91 Cr | 132 Cr | 171 Cr |
| EPS (₹) | ₹13.16 | ₹9.77 | ₹10.13 | ₹12.79 | ₹15.52 | ₹11.60 | ₹18.57 | ₹15.88 | ₹18.05 | ₹5.42 | ₹7.86 | ₹10.15 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 912 Cr | 1,057 Cr | 1,203 Cr | 1,330 Cr | 1,581 Cr | 2,087 Cr | 2,017 Cr | 2,227 Cr | 2,461 Cr | 2,763 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 675 Cr | 793 Cr | 910 Cr | 987 Cr | 1,145 Cr | 1,527 Cr | 1,527 Cr | 1,617 Cr | 1,766 Cr | 1,980 Cr | Sign in free for the trailing twelve months |
| EBITDA | 238 Cr | 264 Cr | 294 Cr | 344 Cr | 436 Cr | 561 Cr | 490 Cr | 609 Cr | 696 Cr | 783 Cr | Sign in free for the trailing twelve months |
| OPM % | 26.0% | 25.0% | 24.4% | 25.8% | 27.6% | 26.9% | 24.3% | 27.4% | 28.3% | 28.3% | Sign in free for the trailing twelve months |
| Other income | 28 Cr | 31 Cr | 46 Cr | 55 Cr | 51 Cr | 53 Cr | 42 Cr | 69 Cr | 93 Cr | 101 Cr | Sign in free for the trailing twelve months |
| Interest | 0.70 Cr | 0.80 Cr | 0.80 Cr | 15 Cr | 16 Cr | 30 Cr | 38 Cr | 29 Cr | 22 Cr | 23 Cr | Sign in free for the trailing twelve months |
| Depreciation | 28 Cr | 33 Cr | 38 Cr | 73 Cr | 77 Cr | 108 Cr | 150 Cr | 144 Cr | 142 Cr | 162 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 237 Cr | 261 Cr | 301 Cr | 311 Cr | 394 Cr | 475 Cr | 344 Cr | 506 Cr | 625 Cr | 669 Cr | Sign in free for the trailing twelve months |
| Tax % | 34.3% | 34.3% | 33.3% | 26.7% | 24.8% | 26.2% | 29.9% | 28.3% | 21.2% | 23.8% | Sign in free for the trailing twelve months |
| Net profit | 156 Cr | 172 Cr | 201 Cr | 228 Cr | 297 Cr | 350 Cr | 241 Cr | 362 Cr | 492 Cr | 510 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹19.02 | ₹20.85 | ₹24.19 | ₹27.42 | ₹35.33 | ₹41.70 | ₹28.82 | ₹43.05 | ₹58.48 | ₹30.24 | Sign in free for the trailing twelve months |
| Dividend payout % | — | — | — | — | 33.6% | 33.3% | 42.7% | 55.5% | 42.1% | 43.7% | Sign in free for the trailing twelve months |
Sign in free for the trailing twelve months
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 83 Cr | 83 Cr | 83 Cr | 83 Cr | 83 Cr | 83 Cr | 83 Cr | 84 Cr | 84 Cr | 168 Cr |
| Reserves | 512 Cr | 708 Cr | 862 Cr | 950 Cr | 1,162 Cr | 1,425 Cr | 1,583 Cr | 1,766 Cr | 2,089 Cr | 2,341 Cr |
| Borrowings | — | — | — | — | 0.10 Cr | 346 Cr | 237 Cr | 83 Cr | — | — |
| Other liabilities | 92 Cr | 124 Cr | 140 Cr | 320 Cr | 385 Cr | 464 Cr | 449 Cr | 487 Cr | 510 Cr | 605 Cr |
| Total liabilities | 690 Cr | 919 Cr | 1,091 Cr | 1,374 Cr | 1,661 Cr | 2,353 Cr | 2,386 Cr | 2,456 Cr | 2,717 Cr | 3,146 Cr |
| Fixed assets (net) | 108 Cr | 160 Cr | 160 Cr | 292 Cr | 306 Cr | 415 Cr | 401 Cr | 343 Cr | 336 Cr | 484 Cr |
| CWIP | 16 Cr | 10 Cr | 3 Cr | 10 Cr | 6 Cr | 14 Cr | 3 Cr | 4 Cr | 4 Cr | 6 Cr |
| Investments | 106 Cr | 145 Cr | 185 Cr | 164 Cr | 59 Cr | 66 Cr | 150 Cr | 148 Cr | 360 Cr | 455 Cr |
| Loans & advances | — | — | 0.90 Cr | 0.90 Cr | 0.90 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr | 2 Cr |
| Inventories | 18 Cr | 27 Cr | 29 Cr | 57 Cr | 43 Cr | 52 Cr | 34 Cr | 37 Cr | 36 Cr | 44 Cr |
| Trade receivables | 42 Cr | 41 Cr | 53 Cr | 51 Cr | 67 Cr | 85 Cr | 71 Cr | 77 Cr | 88 Cr | 111 Cr |
| Cash & bank | 29 Cr | 66 Cr | 129 Cr | 197 Cr | 244 Cr | 378 Cr | 264 Cr | 361 Cr | 293 Cr | 243 Cr |
| Other assets | 372 Cr | 470 Cr | 530 Cr | 602 Cr | 936 Cr | 1,341 Cr | 1,462 Cr | 1,485 Cr | 1,600 Cr | 1,802 Cr |
| Total assets | 690 Cr | 919 Cr | 1,091 Cr | 1,374 Cr | 1,661 Cr | 2,353 Cr | 2,386 Cr | 2,456 Cr | 2,717 Cr | 3,146 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 171 Cr | 197 Cr | 219 Cr | 284 Cr | 398 Cr | 447 Cr | 456 Cr | 535 Cr | 569 Cr | 636 Cr |
| Cash from investing | -137 Cr | -172 Cr | -100 Cr | -26 Cr | -212 Cr | -449 Cr | -287 Cr | -24 Cr | -303 Cr | -422 Cr |
| Cash from financing | -32 Cr | 13 Cr | -55 Cr | -190 Cr | -139 Cr | 136 Cr | -283 Cr | -414 Cr | -334 Cr | -264 Cr |
| Net cash flow | 2 Cr | 37 Cr | 64 Cr | 67 Cr | 48 Cr | 134 Cr | -114 Cr | 97 Cr | -68 Cr | -50 Cr |
| Free cash flow (OCF − Capex) | 120 Cr | 125 Cr | 176 Cr | 204 Cr | 339 Cr | -29 Cr | 411 Cr | 478 Cr | 515 Cr | 462 Cr |
Ratios
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 39.7% | 33.0% | 31.7% | 30.9% | 32.2% | 26.7% | 19.7% | 27.2% | 29.3% | 27.2% |
| ROE % | 25.9% | 21.6% | 20.9% | 21.4% | 22.9% | 22.3% | 14.1% | 19.0% | 22.1% | 19.9% |
| Debtor days | 17 | 14 | 16 | 14 | 15 | 15 | 13 | 13 | 13 | 15 |
| Inventory days | 33 | 44 | 40 | 70 | 39 | 38 | 28 | 30 | 27 | 30 |
| Days payable | 97 | 105 | 111 | 144 | 132 | 107 | 127 | 151 | 150 | 123 |
| Cash conversion cycle | -47 | -47 | -55 | -60 | -78 | -54 | -87 | -108 | -110 | -78 |
| OCF / EBITDA % | 72.1% | 74.6% | 74.4% | 82.6% | 91.3% | 79.7% | 93.1% | 87.9% | 81.8% | 81.2% |
| OCF / EBITDA % (3 years) | — | — | 73.8% | 77.6% | 83.9% | 84.2% | 87.5% | 86.6% | 86.9% | 83.4% |
| Debt / equity | — | — | — | 0.00 | 0.0001 | 0.23 | 0.14 | 0.05 | — | — |
| Current ratio | 5.50 | 5.37 | 5.88 | 3.93 | 4.26 | 1.80 | 2.07 | 2.42 | 3.39 | 3.48 |
| Net debt / EBITDA | -0.12 | — | -0.44 | -0.57 | -0.56 | -0.06 | -0.06 | -0.46 | -0.42 | -0.31 |